The effect of hysterectomy on survival of patients with borderline ovarian tumors

Joseph Menczer*, Angela Chetrit, Siegal Sadetzki, Shmuel Anderman, Marco Alteras, Shaul Anteby, Jack Atad, Amiram Avni, Amiram Bar-Am, Dan Beck, Uziel Beller, Gilad Ben-Baruch, Yehuda Ben-David, Izhar Ben-Shlomo, Haim Biran, Moshe Ben Ami, Shlomit Cohen, Shulamit Cohen, Ram Dgani, Yehudit FishlerAmi Fishman, Eitan Friedman, Ofer Gemer, Ruth Gershoni, Reuvit Halperin, Galit Hirsh-Yechezkel, David Idelman, Rafael Katan, Yuri Kopilovic, Efrat Lahad, Liat Lerner-Geva, Hanoch Levavi, Tally Levy, Albert Levit, Beatriz Lifschitz-Mercer, Flora Lubin, Zohar Leviatan, Jacob Marcovich, Baruch Modan, Hedva Nitzan, Moshe Oetinger, Tamar Perez, Benjamin Piura, David Schneider, Mariana Shteiner, Zion Tal, Chaim Yaffe, Ilana Yanai, Shifra Zohar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Objective: The classically recommended surgical treatment of borderline ovarian tumors (BOTs) includes hysterectomy in addition to bilateral adnexectomy. Possible reasons for hysterectomy might be a high frequency of uterine involvement and its favorable effect on survival. The purpose of the present study was to assess the frequency of uterine involvement in patients with BOTs and the effect of hysterectomy on survival. Methods: All incident cases of histological confirmed BOTs diagnosed in Israeli Jewish women between March 1 1994 and June 30 1999, were identified. Clinical and pathological characteristics were abstracted from medical records. Patients with tumors grossly confined to the ovaries (apparently stage I) were considered to have had surgical staging when at least hysterectomy, bilateral salpingooophorectomy, omentectomy and pelvic lymph node sampling were done. Results: The study group comprised 225 patients. Hysterectomy was performed in 147 (65.31%) patients and uterine involvement was present in only 3 (2.0%) of them. The 13 year survival of the total group of patients was 85.8% and of those in apparent stage I, 88.5%. Among patients with tumors apparently confined to the ovaries, no significant survival difference was observed between unstaged and surgically staged patients. There was also no survival difference between the overall staged and unstaged patients and between patients in stages II-III who did and did not undergo hysterectomy. Conclusions: Our data indicate that the rate of uterine involvement in BOT is low and that hysterectomy does not favorably affect survival. The necessity of hysterectomy in BOT patients is questioned.

Original languageEnglish
Pages (from-to)372-375
Number of pages4
JournalGynecologic Oncology
Issue number2
StatePublished - May 2012


  • Borderline ovarian tumors
  • Effect of hysterectomy on survival
  • Uterine involvement


Dive into the research topics of 'The effect of hysterectomy on survival of patients with borderline ovarian tumors'. Together they form a unique fingerprint.

Cite this